相关实验视频

Updated: Sep 11, 2025

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

长非编码RNANONRATT007487.2通过与CXCL1的直接相互作用驱动癌症诱导的骨疼痛进展

Hui Jiang¹, Lanlan Wang¹, Yiping Xu¹

¹Department of Anesthesiology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.

The Korean journal of pain

|August 18, 2025

概括

长非编码RNANONRATT007487.2通过与CXCL1.1相互作用,促进癌症诱导的骨疼痛 (CIBP). 针对这种相互作用可以缓解与骨转移相关的疼痛.

科学领域:

分子生物学分子生物学
在瘤学瘤学.
疼痛研究疼痛研究

背景情况:

癌症诱导的骨疼痛 (CIBP) 是癌症转移的常见和衰弱的并发症.
长非编码RNAs (lncRNAs) 越来越多地被认为对癌症进展和疼痛的作用,但它们在CIBP中的具体参与尚未完全理解.

研究的目的:

研究 lncRNA NONRATT007487.2 在 CIBP 的发展中的作用.
阐明lncRNA NONRATT007487.2对CIBP的贡献背后的分子机制,重点关注其与CXCL1.1的相互作用.

主要方法:

通过对沃克256乳腺瘤细胞进行内注射来建立CIBP的小鼠模型.
评估疼痛行为使用脚撤回值和延迟测试.
转录组测序,免疫光,RNA光in situ杂交 (FISH) 和RNA拉下测试以识别和验证lncRNANONRATT007487.2和CXCL1.1之间的相互作用.

主要成果:

在患有CIBP的老鼠的脊髓中,IncRNA NONRATT007487.2的调节显著上升.
Knockdown 的 lncRNA NONRATT007487.2 减少了机械和热性过敏症和降低了 CXCL1 的表达.
鱼类和RNA拉下测试证实了lncRNANONRATT007487.2和CXCL1在脊髓中的直接相互作用和同定位.

结论:

lncRNA NONRATT007487.2 是CIBP的关键调节者,通过与CXCL1.1的相互作用起作用.
这种lncRNA-chemokine轴代表了在骨转移患者中治疗疼痛的潜在治疗点.

关键词:

骨新生体骨新生体化学基因CXCL1CXCL1是一种化学基因长时间非编码.神经炎症性疾病神经炎症性疾病没有感觉,没有感觉.疼痛疼痛疼痛疼痛这是一个RNARNARNARNARNA.信号传输信号传输在脊髓中,脊髓是最重要的.转录组转录组就是一个转录组.

更多相关视频

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Non-Canonical Wnt Signaling Pathways

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...

Canonical Wnt Signaling Pathway

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...

RNA Splicing

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...